155156-90-4

Basic information

• Product Name: Ethanone, 1-bicyclo[2.2.2]oct-5-en-2-yl-, [1R-(1alpha,2beta,4alpha)]- (9CI)
• Synonyms: Ethanone, 1-bicyclo[2.2.2]oct-5-en-2-yl-, [1R-(1alpha,2beta,4alpha)]- (9CI)
• CAS NO: 155156-90-4
• Molecular Formula: C10H14O
• Molecular Weight: 150.21756
• Product Categories: ACETYLGROUP
• Mol File: 155156-90-4.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 224.8±29.0 °C(Predicted)
• Appearance: /
• Density: 1.018±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Ethanone, 1-bicyclo[2.2.2]oct-5-en-2-yl-, [1R-(1alpha,2beta,4alpha)]- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-bicyclo[2.2.2]oct-5-en-2-yl-, [1R-(1alpha,2beta,4alpha)]- (9CI)(155156-90-4)
• EPA Substance Registry System: Ethanone, 1-bicyclo[2.2.2]oct-5-en-2-yl-, [1R-(1alpha,2beta,4alpha)]- (9CI)(155156-90-4)

Safety Data

• Hazardous Substances Data: 155156-90-4(Hazardous Substances Data)

Upstream product

• 78-94-4 methyl vinyl ketone 
• 1165952-91-9 cyclohexa-1,3-diene 
• 292638-85-8 acrylic acid methyl ester 
• 54515-89-8 (+)-(1S,2S,4S)-bicyclo[2.2.2]oct-5-en-2-yl methanol 
• 211636-24-7 (1S,2S,4S)-Bicyclo[2.2.2]oct-5-ene-2-carbaldehyde 
• 20507-57-7 (-)-(1S,2S,4S)-bicyclo[2.2.2]oct-5-ene-2-carboxylic acid 
• 110-83-8 cyclohexene 
• 107-02-8 acrolein 

Downstream Products

• 23735-46-8 Bicyclo<2.2.2>oct-2-ylmethylketon 

Relevant articles and documents

-

-

An FT-IR study on Diels-Alder reactions catalysed by heteropoly acid containing sol-gel silica

Following the general trend of using heterogeneous catalysts whenever possible, the replacement of traditional homogeneous Lewis acid catalysts for the Diels-Alder reaction is currently considered in the literature. In this contribution, we report the suc

BTK INHIBITORS

Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions comprising these compounds and their use in therapy. In particular, provided is the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders.

COMPOUNDS USEFUL AS MODULATORS OF TRPM8

The present invention includes compounds useful as modulators of TRPM8, such as compounds of Formulae (Ia), (Ib) and (Ic), and the subgenus and species thereof; personal products containing those compounds; and the use of those compounds and the personal products, particularly the use of increasing or inducing chemesthetic sensations, such as cooling or cold sensations.